Hemostasis Today
NewsFeed
Headlines Hematology Health Medicine VTE ASH Plasma Donation
August, 2026
August 2026
M T W T F S S
 12
3456789
10111213141516
17181920212223
24252627282930
31  
C Michael Gibson: Asundexian Reduces Ischemic Stroke Without Increasing Bleeding Risk
C Michael Gibson/Baim Institute
Feb 7, 2026, 14:25

C Michael Gibson: Asundexian Reduces Ischemic Stroke Without Increasing Bleeding Risk

C Michael Gibson, President and CEO at Baim Institute for Clinical Research, shared on LinkedIn:

”Among patients with non-cardioembolic ischemic stroke or high-risk TIA treated with antiplatelet therapy, asundexian 50 mg reduced the occurrence of ischemic stroke (csHR 0.74; 95% CI, 0.65 to 0.84; p<0.001).

The difference between the treatment arms began early and continued throughout the treatment period.

A consistent effect was seen in subgroups.

Asundexian was associated with a reduction in disabling or fatal stroke (mRS ≥ 3)

Asundexian was not associated with an increase in bleeding Including ISTH major, CRNM, minor or intracranial bleeding.”

C Michael Gibson: Asundexian Reduces Ischemic Stroke Without Increasing Bleeding Risk

Stay updated with Hemostasis Today.

asundexian C. Michael Gibson cardioembolic stroke Health Hematology Hemostasis Hemostasis News Hemostasis Today intracranial bleeding ISTH Medicine stroke thrombosis TIA
NewsFeed